• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amylin Pharmaceuticals

Amylin Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action

    InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action

  2. Stock Star Rating Performance Update

    As 2005 draws to a close, our performance continues to be solid all around, with some bright spots and a few areas for further improvement. Our contrarian stance on large-cap and energy stocks has weighed on our results recently, but we're still confident that those calls will work out in the end. ...

  3. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

  4. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.